Literature DB >> 16636676

Inhibition of medulloblastoma cell invasion by Slit.

T E Werbowetski-Ogilvie1, M Seyed Sadr, N Jabado, A Angers-Loustau, N Y R Agar, J Wu, R Bjerkvig, J P Antel, D Faury, Y Rao, R F Del Maestro.   

Abstract

Invasion of brain tumor cells has made primary malignant brain neoplasms among the most recalcitrant to therapeutic strategies. We tested whether the secreted protein Slit2, which guides the projection of axons and developing neurons, could modulate brain tumor cell invasion. Slit2 inhibited the invasion of medulloblastoma cells in a variety of in vitro models. The effect of Slit2 was inhibited by the Robo ectodomain. Time-lapse videomicroscopy indicated that Slit2 reduced medulloblastoma invasion rate without affecting cell direction or proliferation. Both medulloblastoma and glioma tumors express Robo1 and Slit2, but only medulloblastoma invasion is inhibited by recombinant Slit2 protein. Downregulation of activated Cdc42 may contribute to this differential response. Our findings reinforce the concept that neurodevelopmental cues such as Slit2 may provide insights into brain tumor invasion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636676      PMCID: PMC2072874          DOI: 10.1038/sj.onc.1209524

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

Review 1.  Rho GTPases in neuronal morphogenesis.

Authors:  L Luo
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  Distinctive properties of human adult brain-derived myelin progenitor cells.

Authors:  Francesca Ruffini; Nathalie Arbour; Manon Blain; André Olivier; Jack P Antel
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 3.  Neural stem cells and the origin of gliomas.

Authors:  Nader Sanai; Arturo Alvarez-Buylla; Mitchel S Berger
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

4.  Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells.

Authors:  Edgar R Gomes; Shantanu Jani; Gregg G Gundersen
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

5.  Differential expression of the LGI and SLIT families of genes in human cancer cells.

Authors:  Michael R Rossi; Kristin Huntoon; John K Cowell
Journal:  Gene       Date:  2005-08-15       Impact factor: 3.688

6.  Local endostatin treatment of gliomas administered by microencapsulated producer cells.

Authors:  T A Read; D R Sorensen; R Mahesparan; P O Enger; R Timpl; B R Olsen; M H Hjelstuen; O Haraldseth; R Bjerkvig
Journal:  Nat Biotechnol       Date:  2001-01       Impact factor: 54.908

7.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.

Authors:  T Joki; M Machluf; A Atala; J Zhu; N T Seyfried; I F Dunn; T Abe; R S Carroll; P M Black
Journal:  Nat Biotechnol       Date:  2001-01       Impact factor: 54.908

8.  Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor.

Authors:  G J Bashaw; T Kidd; D Murray; T Pawson; C S Goodman
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

9.  Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.

Authors:  Tamra E Werbowetski-Ogilvie; Nathalie Y R Agar; Roberta M Waldkircher de Oliveira; Damien Faury; Jack P Antel; Nada Jabado; Rolando F Del Maestro
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

10.  Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons.

Authors:  H S Li; J H Chen; W Wu; T Fagaly; L Zhou; W Yuan; S Dupuis; Z H Jiang; W Nash; C Gick; D M Ornitz; J Y Wu; Y Rao
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

View more
  31 in total

1.  Slits affect the timely migration of neural crest cells via Robo receptor.

Authors:  Dion Giovannone; Michelle Reyes; Rachel Reyes; Lisa Correa; Darwin Martinez; Hannah Ra; Gustavo Gomez; Joshua Kaiser; Le Ma; Mary-Pat Stein; Maria Elena de Bellard
Journal:  Dev Dyn       Date:  2012-06-23       Impact factor: 3.780

Review 2.  Slit-Robo interactions during cortical development.

Authors:  William D Andrews; Melissa Barber; John G Parnavelas
Journal:  J Anat       Date:  2007-06-06       Impact factor: 2.610

3.  Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.

Authors:  Cuiling Qi; Haimei Lan; Jie Ye; Weidong Li; Ping Wei; Yang Yang; Simei Guo; Tian Lan; Jiangchao Li; Qianqian Zhang; Xiaodong He; Lijing Wang
Journal:  Lab Invest       Date:  2014-05-19       Impact factor: 5.662

4.  Immunohistochemical staining of slit2 in primary and metastatic prostatic adenocarcinoma.

Authors:  Tanner L Bartholow; Michael J Becich; Uma R Chandran; Anil V Parwani
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

5.  Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity.

Authors:  Jia-Jean Yiin; Bo Hu; Michael J Jarzynka; Haizhong Feng; Kui-Wei Liu; Jane Y Wu; Hsin-I Ma; Shi-Yuan Cheng
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

6.  Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment.

Authors:  Amanda Waterstrat; Ying Liang; Carol F Swiderski; Brent J Shelton; Gary Van Zant
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

7.  The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.

Authors:  J Yu; Q Cao; J Yu; L Wu; A Dallol; J Li; G Chen; C Grasso; X Cao; R J Lonigro; S Varambally; R Mehra; N Palanisamy; J Y Wu; F Latif; A M Chinnaiyan
Journal:  Oncogene       Date:  2010-07-12       Impact factor: 9.867

8.  Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma.

Authors:  Hee Kyung Kim; Hong Zhang; Hui Li; Tsung-Teh Wu; Stephen Swisher; Donggou He; Lizhi Wu; Jianmin Xu; Craig A Elmets; Mohammad Athar; Xìao-chun Xu; Hui Xu
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.

Authors:  Junichi Yuasa-Kawada; Mariko Kinoshita-Kawada; Yi Rao; Jane Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

10.  Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation.

Authors:  Rittwika Bhattacharya; Nupur Mukherjee; Hemantika Dasgupta; Md Saimul Islam; Neyaz Alam; Anup Roy; Priyobrata Das; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.